Wow - to me this is exciting!
Anavex Life Sciences achieves statistical... - Cure Parkinson's
Anavex Life Sciences achieves statistical significance for potential disease modifying therapy for Parkinson's Disease.
Written by
Canddy
To view profiles and participate in discussions please or .
13 Replies
•
Very encouraging. Thanks for sharing!
Comment from Simon (SoPD tweet):
"... need to see more data than this press release, but encouraging indications for Sigma-1 receptor agonists as a potential therapy for Parkinsons."
This sure looks promising! Perhaps there is a glimmer of hope!
For background info, see this August 2020 SoPD blog post from Simon:
Can Sigma-1 get it done?
See also this recent post from John_morris71:
Don't understand a word might aswell be in chinese
Have a look at the SoPD blog post I linked to (above).
There is also now a very readable (IMHO) PNT article:
Oral Anavex 2-73 Eases Dementia, Disease Symptoms in Phase 2 Trial
Exciting! Thank you Canddy!
Not what you're looking for?
You may also like...
Potential disease-modifying therapy enters Phase 2
double-blind, multi-center, placebo-controlled, dose-ranging clinical trial of three IkT 148009...
Citicoline as Adjuvant Therapy in Parkinson's Disease: A Systematic Review 2017
reduction of levodopa by up to 50%. Significant improvement in cognitive status evaluation was also...
Researchers discover a potential cause of Parkinson's disease
bacterial genus correlate with Parkinson's disease, and that their higher number also correlates...
Parkinson's Disease:- \"Parkinson's and the B1 Therapy\" with Daphne Bryan
-------------------------------------------------------
https://youtu.be/iu1vJ8eN8HM